Corvus Pharmaceuticals, Inc.
CRVSBiotechnology
$10.23−2.76%As of Oct 29vs prior close
- Market cap
- $860.6M
- P/E (TTM)
- –
- From 52W high
- −59.91%
- EPS (LTM)
- -$0.64
Nomior Score
49
Steady ProfileBottom 48% of the scored universe
Growth—
Quality53
Value53
Momentum54
Resilience41